Calpain Interactions with the Protein Phosphatase Calcineurin in Neurodegeneration

Chapter
Part of the Advances in Biochemistry in Health and Disease book series (ABHD, volume 8)

Abstract

Dysregulation of intracellular Ca2+ is a major cause of neurologic dysfunction and likely plays an important role in the pathophysiology of numerous acute and chronic neurodegenerative conditions. The Ca2+-dependent protease, calpain, and the Ca2+/calmodulin (Ca2+/CaM)-dependent protein phosphatase, calcineurin, are primary effectors of multiple deleterious functions arising from altered Ca2+ handling. Increasing evidence suggests that the calpain-dependent, irreversible conversion of calcineurin to a constitutively active phosphatase occurs in intact cellular systems as a result of injury and disease. In this chapter, a brief overview of calpain and calcineurin functions in nervous tissue is given, followed by a more in-depth discussion of calpain/calcineurin interactions in vitro and in vivo. Particular emphasis is placed on recent studies that have identified calpain proteolysis of calcineurin as a key step in neurodegeneration associated with acute neurologic insults as well as chronic terminal diseases, like Alzheimer’s.

Keywords

Protease Phosphatase Calcium Ischemia Alzheimer’s Neurodegeneration Dementia 

References

  1. 1.
    Gibson GE, C Peterson (1987) Calcium and the aging nervous system. Neurobiol Aging 8:329-343.PubMedGoogle Scholar
  2. 2.
    Khachaturian ZS (1987) Hypothesis on the regulation of cytosol calcium concentration and the aging brain. Neurobiol Aging 8:345-346.PubMedGoogle Scholar
  3. 3.
    Landfield PW, TA Pitler (1984) Prolonged Ca2+-dependent after hyperpolarizations in hippocampal neurons of aged rats. Science 226:1089-1092.PubMedGoogle Scholar
  4. 4.
    Landfield PW, TA Pitler, MD Applegate (1986) The effects of high Mg2+-to-Ca2+ ratios on frequency potentiation in hippocampal slices of young and aged rats. J Neurophysiol 56:797-811.PubMedGoogle Scholar
  5. 5.
    Choi DW (1985) Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58:293-297.PubMedGoogle Scholar
  6. 6.
    Choi DW (1987) Ionic dependence of glutamate neurotoxicity. J Neurosci 7:369-379.PubMedGoogle Scholar
  7. 7.
    Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.PubMedGoogle Scholar
  8. 8.
    Choi DW (1988) Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci 11:465-469.PubMedGoogle Scholar
  9. 9.
    Choi DW (1994) Calcium and excitotoxic neuronal injury. Ann N Y Acad Sci 747:162-171.PubMedGoogle Scholar
  10. 10.
    Gibson G, P Perrino, GA Dienel (1986) In vivo brain calcium homeostasis during aging. Mech Ageing Dev 37:1-12.PubMedGoogle Scholar
  11. 11.
    Khachaturian ZS (1989) The role of calcium regulation in brain aging: reexamination of a hypothesis. Aging (Milano) 1:17-34.Google Scholar
  12. 12.
    Landfield PW (1987) ‘Increased calcium-current’ hypothesis of brain aging. Neurobiol Aging 8:346-347.PubMedGoogle Scholar
  13. 13.
    Landfield PW, LW Campbell, SY Hao, et al (1989) Aging-related increases in voltage-sensitive, inactivating calcium currents in rat hippocampus. Implications for mechanisms of brain aging and Alzheimer’s disease. Ann N Y Acad Sci 568:95-105.PubMedGoogle Scholar
  14. 14.
    Abdul HM, JL Furman, MA Sama, et al (2010) NFATs and Alzheimer’s Disease. Mol Cell Pharmacol 2:7-14.PubMedGoogle Scholar
  15. 15.
    Berridge MJ (2012) Calcium signalling remodelling and disease. Biochem Soc Trans 40:297-309.PubMedGoogle Scholar
  16. 16.
    Bezprozvanny I, MP Mattson (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer’s disease. Trends Neurosci 31:454-463.PubMedGoogle Scholar
  17. 17.
    Crish SD, DJ Calkins (2011) Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms. Neuroscience 176:1-11.PubMedGoogle Scholar
  18. 18.
    Gasperini RJ, DH Small (2012) Neurodegeneration in familial amyloidotic polyneuropathy. Clin Exp Pharmacol Physiol 39:680-683.PubMedGoogle Scholar
  19. 19.
    Goodison WV, V Frisardi, PG Kehoe (2012) Calcium channel blockers and Alzheimer’s disease: potential relevance in treatment strategies of metabolic syndrome. J Alzheimers Dis 30 Suppl 2:S269-282.PubMedGoogle Scholar
  20. 20.
    Green KN, FM LaFerla (2008) Linking calcium to Abeta and Alzheimer’s disease. Neuron 59:190-194.PubMedGoogle Scholar
  21. 21.
    Stutzmann GE, MP Mattson (2011) Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease. Pharmacol Rev 63:700-727.PubMedGoogle Scholar
  22. 22.
    Thibault O, JC Gant, PW Landfield (2007) Expansion of the calcium hypothesis of brain aging and Alzheimer’s disease: minding the store. Aging Cell 6:307-317.PubMedGoogle Scholar
  23. 23.
    Toescu EC, A Verkhratsky, PW Landfield (2004) Ca(2+) regulation and gene expression in normal brain aging. Trends Neurosci 27:614-620.PubMedGoogle Scholar
  24. 24.
    Campbell RL, PL Davies (2012) Structure-function relationships in calpains. Biochem J 447:335-351.PubMedGoogle Scholar
  25. 25.
    Goll DE, VF Thompson, H Li, et al (2003) The calpain system. Physiol Rev 83:731-801.PubMedGoogle Scholar
  26. 26.
    Nixon RA (2003) The calpains in aging and aging-related diseases. Ageing Res Rev 2:407-418.PubMedGoogle Scholar
  27. 27.
    Ono Y, H Sorimachi (2012) Calpains: an elaborate proteolytic system. Biochim Biophys Acta 1824:224-236.PubMedGoogle Scholar
  28. 28.
    Mansuy IM (2003) Calcineurin in memory and bidirectional plasticity. Biochem Biophys Res Commun 311:1195-1208.PubMedGoogle Scholar
  29. 29.
    Musson RE, NP Smit (2011) Regulatory mechanisms of calcineurin phosphatase activity. Curr Med Chem 18:301-315.PubMedGoogle Scholar
  30. 30.
    Rusnak F, P Mertz (2000) Calcineurin: form and function. Physiol Rev 80:1483-1521.PubMedGoogle Scholar
  31. 31.
    Gil-Parrado S, O Popp, TA Knoch, et al (2003) Subcellular localization and in vivo subunit interactions of ubiquitous mu-calpain. J Biol Chem 278:16336-16346.PubMedGoogle Scholar
  32. 32.
    Yoshizawa T, H Sorimachi, S Tomioka, et al (1995) Calpain dissociates into subunits in the presence of calcium ions. Biochem Biophys Res Commun 208:376-383.PubMedGoogle Scholar
  33. 33.
    Nixon RA (1986) Fodrin degradation by calcium-activated neutral proteinase (CANP) in retinal ganglion cell neurons and optic glia: preferential localization of CANP activities in neurons. J Neurosci 6:1264-1271.PubMedGoogle Scholar
  34. 34.
    Siman R (1992) Proteolytic mechanism for the neurodegeneration of Alzheimer’s disease. Ann N Y Acad Sci 674:193-202.PubMedGoogle Scholar
  35. 35.
    Siman R, M Baudry, G Lynch (1984) Brain fodrin: substrate for calpain I, an endogenous calcium-activated protease. Proc Natl Acad Sci U S A 81:3572-3576.PubMedGoogle Scholar
  36. 36.
    D’Orsi B, H Bonner, LP Tuffy, et al (2012) Calpains are downstream effectors of bax-dependent excitotoxic apoptosis. J Neurosci 32:1847-1858.PubMedGoogle Scholar
  37. 37.
    Siman R, M Baudry, G Lynch (1985) Regulation of glutamate receptor binding by the cytoskeletal protein fodrin. Nature 313:225-228.PubMedGoogle Scholar
  38. 38.
    Bi X, V Chang, E Molnar, et al (1996) The C-terminal domain of glutamate receptor subunit 1 is a target for calpain-mediated proteolysis. Neuroscience 73:903-906.PubMedGoogle Scholar
  39. 39.
    Bi X, J Chen, S Dang, et al (1997) Characterization of calpain-mediated proteolysis of GluR1 subunits of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptors in rat brain. J Neurochem 68:1484-1494.PubMedGoogle Scholar
  40. 40.
    Bi X, Y Rong, J Chen, et al (1998) Calpain-mediated regulation of NMDA receptor structure and function. Brain Res 790:245-253.PubMedGoogle Scholar
  41. 41.
    Bi X, G Tocco, M Baudry (1994) Calpain-mediated regulation of AMPA receptors in adult rat brain. Neuroreport 6:61-64.PubMedGoogle Scholar
  42. 42.
    Dong YN, EA Waxman, DR Lynch (2004) Interactions of postsynaptic density-95 and the NMDA receptor 2 subunit control calpain-mediated cleavage of the NMDA receptor. J Neurosci 24:11035-11045.PubMedGoogle Scholar
  43. 43.
    Gascon S, M Sobrado, JM Roda, et al (2008) Excitotoxicity and focal cerebral ischemia induce truncation of the NR2A and NR2B subunits of the NMDA receptor and cleavage of the scaffolding protein PSD-95. Mol Psychiatry 13:99-114.PubMedGoogle Scholar
  44. 44.
    Jourdi H, X Lu, T Yanagihara, et al (2005) Prolonged positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors induces calpain-mediated PSD-95/Dlg/ZO-1 protein degradation and AMPA receptor down-regulation in cultured hippocampal slices. J Pharmacol Exp Ther 314:16-26.PubMedGoogle Scholar
  45. 45.
    Lu X, Y Rong, M Baudry (2000) Calpain-mediated degradation of PSD-95 in developing and adult rat brain. Neurosci Lett 286:149-153.PubMedGoogle Scholar
  46. 46.
    Sessoms JS, SJ Chen, DM Chetkovich, et al (1992) Ca(2+)-induced persistent protein kinase C activation in rat hippocampal homogenates. Second Messengers Phosphoproteins 14:109-126.PubMedGoogle Scholar
  47. 47.
    Suzuki T, K Okumura-Noji, A Ogura, et al (1992) Calpain may produce a Ca(2+)-independent form of kinase C in long-term potentiation. Biochem Biophys Res Commun 189:1515-1520.PubMedGoogle Scholar
  48. 48.
    Wu HY, K Tomizawa, Y Oda, et al (2004) Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J Biol Chem 279:4929-4940.PubMedGoogle Scholar
  49. 49.
    Kuwako K, I Nishimura, T Uetsuki, et al (2002) Activation of calpain in cultured neurons overexpressing Alzheimer amyloid precursor protein. Brain Res Mol Brain Res 107:166-175.PubMedGoogle Scholar
  50. 50.
    Mohmmad Abdul H, I Baig, H Levine, 3rd, et al (2011) Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric Abeta in primary cell culture. Aging Cell 10:103-113.PubMedGoogle Scholar
  51. 51.
    Tamada Y, C Fukiage, S Daibo, et al (2002) Involvement of calpain in hypoxia-induced damage in rat retina in vitro. Comp Biochem Physiol B Biochem Mol Biol 131:221-225.PubMedGoogle Scholar
  52. 52.
    Blomgren K, C Zhu, X Wang, et al (2001) Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of “pathological apoptosis”? J Biol Chem 276:10191-10198.PubMedGoogle Scholar
  53. 53.
    Ostwald K, H Hagberg, P Andine, et al (1993) Upregulation of calpain activity in neonatal rat brain after hypoxic-ischemia. Brain Res 630:289-294.PubMedGoogle Scholar
  54. 54.
    Bi X, V Chang, R Siman, et al (1996) Regional distribution and time-course of calpain activation following kainate-induced seizure activity in adult rat brain. Brain Res 726:98-108.PubMedGoogle Scholar
  55. 55.
    Schoch KM, HN Evans, JM Brelsfoard, et al (2012) Calpastatin overexpression limits calpain-mediated proteolysis and behavioral deficits following traumatic brain injury. Exp Neurol 236:371-382.PubMedGoogle Scholar
  56. 56.
    McGinn MJ, BJ Kelley, L Akinyi, et al (2009) Biochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion. J Neuropathol Exp Neurol 68:241-249.PubMedGoogle Scholar
  57. 57.
    Saatman KE, D Bozyczko-Coyne, V Marcy, et al (1996) Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J Neuropathol Exp Neurol 55:850-860.PubMedGoogle Scholar
  58. 58.
    Liu F, I Grundke-Iqbal, K Iqbal, et al (2005) Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J Biol Chem 280:37755-37762.PubMedGoogle Scholar
  59. 59.
    Saito K, JS Elce, JE Hamos, et al (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A 90:2628-2632.PubMedGoogle Scholar
  60. 60.
    Mouatt-Prigent A, JO Karlsson, Y Agid, et al (1996) Increased M-calpain expression in the mesencephalon of patients with Parkinson’s disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience 73:979-987.PubMedGoogle Scholar
  61. 61.
    Shields DC, KE Schaecher, TC Saido, et al (1999) A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. Proc Natl Acad Sci U S A 96:11486-11491.PubMedGoogle Scholar
  62. 62.
    Huang W, J Fileta, I Rawe, et al (2010) Calpain activation in experimental glaucoma. Invest Ophthalmol Vis Sci 51:3049-3054.PubMedGoogle Scholar
  63. 63.
    Oka T, Y Tamada, E Nakajima, et al (2006) Presence of calpain-induced proteolysis in retinal degeneration and dysfunction in a rat model of acute ocular hypertension. J Neurosci Res 83:1342-1351.PubMedGoogle Scholar
  64. 64.
    Crocker SJ, PD Smith, V Jackson-Lewis, et al (2003) Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson’s disease. J Neurosci 23:4081-4091.PubMedGoogle Scholar
  65. 65.
    Das A, DP Garner, AM Del Re, et al (2006) Calpeptin provides functional neuroprotection to rat retinal ganglion cells following Ca2+ influx. Brain Res 1084:146-157.PubMedGoogle Scholar
  66. 66.
    Grant RJ, LH Sellings, SJ Crocker, et al (2009) Effects of calpain inhibition on dopaminergic markers and motor function following intrastriatal 6-hydroxydopamine administration in rats. Neuroscience 158:558-569.PubMedGoogle Scholar
  67. 67.
    Hassen GW, J Feliberti, L Kesner, et al (2008) Prevention of axonal injury using calpain inhibitor in chronic progressive experimental autoimmune encephalomyelitis. Brain Res 1236:206-215.PubMedGoogle Scholar
  68. 68.
    Trinchese F, M Fa, S Liu, et al (2008) Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. J Clin Invest 118:2796-2807.PubMedGoogle Scholar
  69. 69.
    Vaisid T, NS Kosower, A Katzav, et al (2007) Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer’s disease. Neurochem Int 51:391-397.PubMedGoogle Scholar
  70. 70.
    Chen Q, M Paillard, L Gomez, et al (2011) Activation of mitochondrial mu-calpain increases AIF cleavage in cardiac mitochondria during ischemia-reperfusion. Biochem Biophys Res Commun 415:533-538.PubMedGoogle Scholar
  71. 71.
    Choi WS, EH Lee, CW Chung, et al (2001) Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2. J Neurochem 77:1531-1541.PubMedGoogle Scholar
  72. 72.
    McGinnis KM, ME Gnegy, YH Park, et al (1999) Procaspase-3 and poly(ADP)ribose polymerase (PARP) are calpain substrates. Biochem Biophys Res Commun 263:94-99.PubMedGoogle Scholar
  73. 73.
    Ozaki T, T Yamashita, S Ishiguro (2009) Mitochondrial m-calpain plays a role in the release of truncated apoptosis-inducing factor from the mitochondria. Biochim Biophys Acta 1793:1848-1859.PubMedGoogle Scholar
  74. 74.
    Valero JG, A Cornut-Thibaut, R Juge, et al (2012) micro-Calpain conversion of antiapoptotic Bfl-1 (BCL2A1) into a prodeath factor reveals two distinct alpha-helices inducing mitochondria-mediated apoptosis. PLoS One 7:e38620.Google Scholar
  75. 75.
    Kopil CM, AP Siebert, JK Foskett, et al (2012) Calpain-cleaved type 1 inositol 1,4,5-trisphosphate receptor impairs ER Ca(2+) buffering and causes neurodegeneration in primary cortical neurons. J Neurochem 123:147-158.PubMedGoogle Scholar
  76. 76.
    Kopil CM, H Vais, KH Cheung, et al (2011) Calpain-cleaved type 1 inositol 1,4,5-trisphosphate receptor (InsP(3)R1) has InsP(3)-independent gating and disrupts intracellular Ca(2+) homeostasis. J Biol Chem 286:35998-36010.PubMedGoogle Scholar
  77. 77.
    Pottorf WJ, 2nd, TM Johanns, SM Derrington, et al (2006) Glutamate-induced protease-mediated loss of plasma membrane Ca2+ pump activity in rat hippocampal neurons. J Neurochem 98:1646-1656.PubMedGoogle Scholar
  78. 78.
    Hell JW, RE Westenbroek, LJ Breeze, et al (1996) N-methyl-D-aspartate receptor-induced proteolytic conversion of postsynaptic class C L-type calcium channels in hippocampal neurons. Proc Natl Acad Sci U S A 93:3362-3367.PubMedGoogle Scholar
  79. 79.
    Kissinger CR, HE Parge, DR Knighton, et al (1995) Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 378:641-644.PubMedGoogle Scholar
  80. 80.
    Stemmer PM, CB Klee (1994) Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B published erratum appears in Biochemistry 1995 Dec 5;34(48):15880.. Biochemistry 33:6859-6866.PubMedGoogle Scholar
  81. 81.
    Wu HY, E Hudry, T Hashimoto, et al (2012) Distinct dendritic spine and nuclear phases of calcineurin activation after exposure to amyloid-beta revealed by a novel fluorescence resonance energy transfer assay. J Neurosci 32:5298-5309.PubMedGoogle Scholar
  82. 82.
    Li N, Z Zhang, W Zhang, et al (2011) Calcineurin B subunit interacts with proteasome subunit alpha type 7 and represses hypoxia-inducible factor-1alpha activity via the proteasome pathway. Biochem Biophys Res Commun 405:468-472.PubMedGoogle Scholar
  83. 83.
    Li W, RE Handschumacher (2002) Identification of two calcineurin B-binding proteins: tubulin and heat shock protein 60. Biochim Biophys Acta 1599:72-81.PubMedGoogle Scholar
  84. 84.
    Liu L, Z Su, S Xin, et al (2012) The calcineurin B subunit (CnB) is a new ligand of integrin alphaM that mediates CnB-induced Apo2L/TRAIL expression in macrophages. J Immunol 188:238-247.PubMedGoogle Scholar
  85. 85.
    Saeki M, Y Irie, L Ni, et al (2007) Calcineurin potentiates the activation of procaspase-3 by accelerating its proteolytic maturation. J Biol Chem 282:11786-11794.PubMedGoogle Scholar
  86. 86.
    Kuno T, H Mukai, A Ito, et al (1992) Distinct cellular expression of calcineurin A alpha and A beta in rat brain. J Neurochem 58:1643-1651.PubMedGoogle Scholar
  87. 87.
    Abdul HM, MA Sama, JL Furman, et al (2009) Cognitive decline in Alzheimer’s disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci 29:12957-12969.PubMedGoogle Scholar
  88. 88.
    Aramburu J, J Heitman, GR Crabtree (2004) Calcineurin: a central controller of signalling in eukaryotes. EMBO Rep 5:343-348.PubMedGoogle Scholar
  89. 89.
    Baine I, BT Abe, F Macian (2009) Regulation of T-cell tolerance by calcium/NFAT signaling. Immunol Rev 231:225-240.PubMedGoogle Scholar
  90. 90.
    Takaishi T, N Saito, T Kuno, et al (1991) Differential distribution of the mRNA encoding two isoforms of the catalytic subunit of calcineurin in the rat brain. Biochem Biophys Res Commun 174:393-398.PubMedGoogle Scholar
  91. 91.
    de Leon MJ, A Convit, S DeSanti, et al (1995) The hippocampus in aging and Alzheimer’s disease. Neuroimaging Clin N Am 5:1-17.PubMedGoogle Scholar
  92. 92.
    Scheff SW, DA Price (2006) Alzheimer’s disease-related alterations in synaptic density: neocortex and hippocampus. J Alzheimers Dis 9:101-115.PubMedGoogle Scholar
  93. 93.
    Klee CB, TH Crouch, MH Krinks (1979) Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proc Natl Acad Sci U S A 76:6270-6273.PubMedGoogle Scholar
  94. 94.
    Goto S, Y Matsukado, Y Mihara, et al (1986) The distribution of calcineurin in rat brain by light and electron microscopic immunohistochemistry and enzyme-immunoassay. Brain Res 397:161-172.PubMedGoogle Scholar
  95. 95.
    Celsi F, M Svedberg, C Unger, et al (2007) Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiol Dis 26:342-352.PubMedGoogle Scholar
  96. 96.
    Hashimoto T, T Kawamata, N Saito, et al (1998) Isoform-specific redistribution of calcineurin A alpha and A beta in the hippocampal CA1 region of gerbils after transient ischemia. J Neurochem 70:1289-1298.PubMedGoogle Scholar
  97. 97.
    Norris CM, I Kadish, EM Blalock, et al (2005) Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer’s models. J Neurosci 25:4649-4658.PubMedGoogle Scholar
  98. 98.
    Halpain S, P Greengard (1990) Activation of NMDA receptors induces rapid dephosphorylation of the cytoskeletal protein MAP2. Neuron 5:237-246.PubMedGoogle Scholar
  99. 99.
    Meberg PJ, S Ono, LS Minamide, et al (1998) Actin depolymerizing factor and cofilin phosphorylation dynamics: response to signals that regulate neurite extension. Cell Motil Cytoskeleton 39:172-190.PubMedGoogle Scholar
  100. 100.
    Wang Y, F Shibasaki, K Mizuno (2005) Calcium signal-induced cofilin dephosphorylation is mediated by Slingshot via calcineurin. J Biol Chem 280:12683-12689.PubMedGoogle Scholar
  101. 101.
    Snyder GL, S Galdi, AA Fienberg, et al (2003) Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists. Neuropharmacology 45:703-713.PubMedGoogle Scholar
  102. 102.
    Kam AY, D Liao, HH Loh, et al (2010) Morphine induces AMPA receptor internalization in primary hippocampal neurons via calcineurin-dependent dephosphorylation of GluR1 subunits. J Neurosci 30:15304-15316.PubMedGoogle Scholar
  103. 103.
    Kim SM, SM Ahn, BS Go, et al (2009) Alterations in AMPA receptor phosphorylation in the rat striatum following acute and repeated cocaine administration. Neuroscience 163:618-626.PubMedGoogle Scholar
  104. 104.
    Unoki T, S Matsuda, W Kakegawa, et al (2012) NMDA receptor-mediated PIP5K activation to produce PI(4,5)P(2) is essential for AMPA receptor endocytosis during LTD. Neuron 73:135-148.PubMedGoogle Scholar
  105. 105.
    Malinow R, RC Malenka (2002) AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 25:103-126.PubMedGoogle Scholar
  106. 106.
    Bito H, K Deisseroth, RW Tsien (1996) CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression. Cell 87:1203-1214.PubMedGoogle Scholar
  107. 107.
    Lin CH, SH Yeh, HY Lu, et al (2003) The similarities and diversities of signal pathways leading to consolidation of conditioning and consolidation of extinction of fear memory. J Neurosci 23:8310-8317.PubMedGoogle Scholar
  108. 108.
    Macian F (2005) NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5:472-484.PubMedGoogle Scholar
  109. 109.
    Graef IA, PG Mermelstein, K Stankunas, et al (1999) L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature 401:703-708.PubMedGoogle Scholar
  110. 110.
    Groth RD, PG Mermelstein (2003) Brain-derived neurotrophic factor activation of NFAT (nuclear factor of activated T-cells)-dependent transcription: a role for the transcription factor NFATc4 in neurotrophin-mediated gene expression. J Neurosci 23:8125-8134.PubMedGoogle Scholar
  111. 111.
    Canellada A, BG Ramirez, T Minami, et al (2008) Calcium/calcineurin signaling in primary cortical astrocyte cultures: Rcan1-4 and cyclooxygenase-2 as NFAT target genes. Glia 56:709-722.PubMedGoogle Scholar
  112. 112.
    Fernandez AM, S Fernandez, P Carrero, et al (2007) Calcineurin in reactive astrocytes plays a key role in the interplay between proinflammatory and anti-inflammatory signals. J Neurosci 27:8745-8756.PubMedGoogle Scholar
  113. 113.
    Sama MA, DM Mathis, JL Furman, et al (2008) Interleukin-1beta-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity. J Biol Chem 283:21953-21964.PubMedGoogle Scholar
  114. 114.
    Reese LC, G Taglialatela (2011) A role for calcineurin in Alzheimer’s disease. Curr Neuropharmacol 9:685-692.PubMedGoogle Scholar
  115. 115.
    Halpain S, A Hipolito, L Saffer (1998) Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. J Neurosci 18:9835-9844.PubMedGoogle Scholar
  116. 116.
    Shankar GM, BL Bloodgood, M Townsend, et al (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866-2875.PubMedGoogle Scholar
  117. 117.
    Tackenberg C, R Brandt (2009) Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau. J Neurosci 29:14439-14450.PubMedGoogle Scholar
  118. 118.
    Wu HY, E Hudry, T Hashimoto, et al (2010) Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J Neurosci 30:2636-2649.PubMedGoogle Scholar
  119. 119.
    Wang HG, N Pathan, IM Ethell, et al (1999) Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284:339-343.PubMedGoogle Scholar
  120. 120.
    Springer JE, RD Azbill, SA Nottingham, et al (2000) Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury. J Neurosci 20:7246-7251.PubMedGoogle Scholar
  121. 121.
    Shioda N, F Han, S Moriguchi, et al (2007) Constitutively active calcineurin mediates delayed neuronal death through Fas-ligand expression via activation of NFAT and FKHR transcriptional activities in mouse brain ischemia. J Neurochem 102:1506-1517.PubMedGoogle Scholar
  122. 122.
    Nagamoto-Combs K, CK Combs (2010) Microglial phenotype is regulated by activity of the transcription factor, NFAT (nuclear factor of activated T cells). J Neurosci 30:9641-9646.PubMedGoogle Scholar
  123. 123.
    Carafoli E, A Genazzani, D Geurini (1999) Calcium controls the transcription of its own transporters and channels in developing neurons. Biochem Biophys Res Comm 266:624-632.PubMedGoogle Scholar
  124. 124.
    Groth RD, RL Dunbar, PG Mermelstein (2003) Calcineurin regulation of neuronal plasticity. Biochem Biophys Res Commun 311:1159-1171.PubMedGoogle Scholar
  125. 125.
    Norris CM, EM Blalock, KC Chen, et al (2010) Hippocampal ‘zipper’ slice studies reveal a necessary role for calcineurin in the increased activity of L-type Ca(2+) channels with aging. Neurobiol Aging 31:328-338.PubMedGoogle Scholar
  126. 126.
    Kurz JE, JT Parsons, A Rana, et al (2005) A significant increase in both basal and maximal calcineurin activity following fluid percussion injury in the rat. J Neurotrauma 22:476-490.PubMedGoogle Scholar
  127. 127.
    Miletic G, KM Sullivan, AM Dodson, et al (2011) Changes in calcineurin message, enzyme activity and protein content in the spinal dorsal horn are associated with chronic constriction injury of the rat sciatic nerve. Neuroscience 188:142-147.PubMedGoogle Scholar
  128. 128.
    Foster TC, KM Sharrow, JR Masse, et al (2001) Calcineurin links Ca2+ dysregulation with brain aging. J Neurosci 21:4066-4073.PubMedGoogle Scholar
  129. 129.
    Dineley KT, D Hogan, WR Zhang, et al (2007) Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice. Neurobiol Learn Mem 88:217-224.PubMedGoogle Scholar
  130. 130.
    Cho HJ, SM Jin, HD Youn, et al (2008) Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling. Aging Cell 7:137-147.PubMedGoogle Scholar
  131. 131.
    Norris CM, S Halpain, TC Foster (1998) Alterations in the balance of protein kinase/phosphatase activities parallel reduced synaptic strength during aging. J Neurophysiol 80:1567-1570.PubMedGoogle Scholar
  132. 132.
    Furman JL, DM Sama, JC Gant, et al (2012) Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer’s disease. J Neurosci 32:16129-16140.PubMedGoogle Scholar
  133. 133.
    Hudry E, HY Wu, M Arbel-Ornath, et al (2012) Inhibition of the NFAT pathway alleviates amyloid beta neurotoxicity in a mouse model of Alzheimer’s disease. J Neurosci 32:3176-3192.PubMedGoogle Scholar
  134. 134.
    Kuchibhotla KV, ST Goldman, CR Lattarulo, et al (2008) Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59:214-225.PubMedGoogle Scholar
  135. 135.
    Yoshiyama Y, M Higuchi, B Zhang, et al (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53:337-351.PubMedGoogle Scholar
  136. 136.
    Zawadzka M, B Kaminska (2005) A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells. Glia 49:36-51.PubMedGoogle Scholar
  137. 137.
    Kaminska B, K Gaweda-Walerych, M Zawadzka (2004) Molecular mechanisms of neuroprotective action of immunosuppressants – facts and hypotheses. J Cell Mol Med 8:45-58.PubMedGoogle Scholar
  138. 138.
    Saganova K, J Galik, J Blasko, et al (2012) Immunosuppressant FK506: focusing on neuroprotective effects following brain and spinal cord injury. Life Sci 91:77-82.PubMedGoogle Scholar
  139. 139.
    Rozkalne A, BT Hyman, TL Spires-Jones (2011) Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice. Neurobiol Dis 41:650-654.PubMedGoogle Scholar
  140. 140.
    Hong HS, JY Hwang, SM Son, et al (2010) FK506 reduces amyloid plaque burden and induces MMP-9 in AbetaPP/PS1 double transgenic mice. J Alzheimers Dis 22:97-105.PubMedGoogle Scholar
  141. 141.
    Taglialatela G, D Hogan, WR Zhang, et al (2009) Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav Brain Res 200:95-99.Google Scholar
  142. 142.
    Dineley KT, R Kayed, V Neugebauer, et al (2010) Amyloid-beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice. J Neurosci Res 88:2923-2932.PubMedGoogle Scholar
  143. 143.
    Vashishta A, A Habas, P Pruunsild, et al (2009) Nuclear factor of activated T-cells isoform c4 (NFATc4/NFAT3) as a mediator of antiapoptotic transcription in NMDA receptor-stimulated cortical neurons. J Neurosci 29:15331-15340.PubMedGoogle Scholar
  144. 144.
    Fernandez AM, S Jimenez, M Mecha, et al (2012) Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer’s pathology. Mol Psychiatry 17:705-718.PubMedGoogle Scholar
  145. 145.
    Sanderson JL, ML Dell’Acqua (2011) AKAP signaling complexes in regulation of excitatory synaptic plasticity. Neuroscientist 17:321-336.PubMedGoogle Scholar
  146. 146.
    Liu JO (2003) Endogenous protein inhibitors of calcineurin. Biochem Biophys Res Commun 311:1103-1109.PubMedGoogle Scholar
  147. 147.
    Hilioti Z, DA Gallagher, ST Low-Nam, et al (2004) GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNs. Genes Dev 18:35-47.PubMedGoogle Scholar
  148. 148.
    Liu Q, JC Busby, JD Molkentin (2009) Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Nat Cell Biol 11:154-161.Google Scholar
  149. 149.
    Ullrich V, D Namgaladze, D Frein (2003) Superoxide as inhibitor of calcineurin and mediator of redox regulation. Toxicol Lett 139:107-110.PubMedGoogle Scholar
  150. 150.
    Klee CB, H Ren, X Wang (1998) Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 273:13367-13370.PubMedGoogle Scholar
  151. 151.
    Quintana AR, D Wang, JE Forbes, et al (2005) Kinetics of calmodulin binding to calcineurin. Biochem Biophys Res Commun 334:674-680.PubMedGoogle Scholar
  152. 152.
    Klee CB (1991) Concerted regulation of protein phosphorylation and dephosphorylation by calmodulin. Neurochem Res 16:1059-1065.PubMedGoogle Scholar
  153. 153.
    Rumi-Masante J, FI Rusinga, TE Lester, et al (2012) Structural basis for activation of calcineurin by calmodulin. J Mol Biol 415:307-317.PubMedGoogle Scholar
  154. 154.
    Manalan AS, CB Klee (1983) Activation of calcineurin by limited proteolysis. Proc Natl Acad Sci U S A 80:4291-4295.PubMedGoogle Scholar
  155. 155.
    Tallant EA, WY Cheung (1984) Activation of bovine brain calmodulin-dependent protein phosphatase by limited trypsinization. Biochemistry 23:973-979.PubMedGoogle Scholar
  156. 156.
    Kincaid RL, PR Giri, S Higuchi, et al (1990) Cloning and characterization of molecular isoforms of the catalytic subunit of calcineurin using nonisotopic methods. J Biol Chem 265:11312-11319.PubMedGoogle Scholar
  157. 157.
    Tallant EA, LM Brumley, RW Wallace (1988) Activation of a calmodulin-dependent phosphatase by a Ca2+-dependent protease. Biochemistry 27:2205-2211.PubMedGoogle Scholar
  158. 158.
    Wang KK, BD Roufogalis, A Villalobo (1989) Characterization of the fragmented forms of calcineurin produced by calpain I. Biochem Cell Biol 67:703-711.PubMedGoogle Scholar
  159. 159.
    Asai A, J Qiu, Y Narita, et al (1999) High level calcineurin activity predisposes neuronal cells to apoptosis. J Biol Chem 274:34450-34458.PubMedGoogle Scholar
  160. 160.
    Winder DG, IM Mansuy, M Osman, et al (1998) Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Cell 92:25-37.PubMedGoogle Scholar
  161. 161.
    Mansuy IM, M Mayford, B Jacob, et al (1998) Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell 92:39-49.PubMedGoogle Scholar
  162. 162.
    Mansuy IM, DG Winder, TM Moallem, et al (1998) Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron 21:257-265.PubMedGoogle Scholar
  163. 163.
    Lakshmikuttyamma A, P Selvakumar, R Kakkar, et al (2003) Activation of calcineurin expression in ischemia-reperfused rat heart and in human ischemic myocardium. J Cell Biochem 90:987-997.PubMedGoogle Scholar
  164. 164.
    Burkard N, J Becher, C Heindl, et al (2005) Targeted proteolysis sustains calcineurin activation. Circulation 111:1045-1053.PubMedGoogle Scholar
  165. 165.
    Braak H, E Braak (1996) Evolution of the neuropathology of Alzheimer’s disease. Acta Neurol Scand Suppl 165:3-12.PubMedGoogle Scholar
  166. 166.
    McGeer EG, PL McGeer (2010) Neuroinflammation in Alzheimer’s disease and mild cognitive impairment: a field in its infancy. J Alzheimers Dis 19:355-361.PubMedGoogle Scholar
  167. 167.
    Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12:1005-1015.PubMedGoogle Scholar
  168. 168.
    Molinuevo JL, A Llado, L Rami (2005) Memantine: targeting glutamate excitotoxicity in Alzheimer’s disease and other dementias. Am J Alzheimers Dis Other Demen 20:77-85.PubMedGoogle Scholar
  169. 169.
    Hynd MR, HL Scott, PR Dodd (2004) Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer’s disease. Neurochem Int 45:583-595.PubMedGoogle Scholar
  170. 170.
    Qian W, X Yin, W Hu, et al (2011) Activation of protein phosphatase 2B and hyperphosphorylation of Tau in Alzheimer’s disease. J Alzheimers Dis 23:617-627.PubMedGoogle Scholar
  171. 171.
    Mufson EJ, L Binder, SE Counts, et al (2012) Mild cognitive impairment: pathology and mechanisms. Acta Neuropathol 123:13-30.PubMedGoogle Scholar
  172. 172.
    Li Q, J Fang, M Yang, et al (2010) Galantamine inhibits calpain-calcineurin signaling activated by beta-amyloid in human neuroblastoma SH-SY5Y cells. Neurosci Lett 480:173-177.Google Scholar
  173. 173.
    Rosenkranz K, C May, C Meier, et al (2012) Proteomic analysis of alterations induced by perinatal hypoxic-ischemic brain injury. J Proteome Res 11:5794-5803.PubMedGoogle Scholar
  174. 174.
    Shioda N, S Moriguchi, Y Shirasaki, et al (2006) Generation of constitutively active calcineurin by calpain contributes to delayed neuronal death following mouse brain ischemia. J Neurochem 98:310-320.PubMedGoogle Scholar
  175. 175.
    Quigley HA, RW Nickells, LA Kerrigan, et al (1995) Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 36:774-786.PubMedGoogle Scholar
  176. 176.
    Guo L, SE Moss, RA Alexander, et al (2005) Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci 46:175-182.PubMedGoogle Scholar
  177. 177.
    Nickells RW, GR Howell, I Soto, et al (2012) Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Annu Rev Neurosci 35:153-179.PubMedGoogle Scholar
  178. 178.
    Huang W, JB Fileta, A Dobberfuhl, et al (2005) Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma. Proc Natl Acad Sci U S A 102:12242-12247.PubMedGoogle Scholar
  179. 179.
    Shields DC, KE Schaecher, EL Hogan, et al (2000) Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesion. J Neurosci Res 61:146-150.PubMedGoogle Scholar
  180. 180.
    Shields DC, WR Tyor, GE Deibler, et al (1998) Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A 95:5768-5772.PubMedGoogle Scholar
  181. 181.
    Shields DC, WR Tyor, GE Deibler, et al (1998) Increased calpain expression in experimental demyelinating optic neuritis: an immunocytochemical study. Brain Res 784:299-304.PubMedGoogle Scholar
  182. 182.
    Feng ZH, J Hao, L Ye, et al (2011) Overexpression of mu-calpain in the anterior temporal neocortex of patients with intractable epilepsy correlates with clinicopathological characteristics. Seizure 20:395-401.PubMedGoogle Scholar
  183. 183.
    Gray BC, P Skipp, VM O’Connor, et al (2006) Increased expression of glial fibrillary acidic protein fragments and mu-calpain activation within the hippocampus of prion-infected mice. Biochem Soc Trans 34:51-54.PubMedGoogle Scholar
  184. 184.
    Cao X, Y Zhang, L Zou, et al (2010) Persistent oxygen-glucose deprivation induces astrocytic death through two different pathways and calpain-mediated proteolysis of cytoskeletal proteins during astrocytic oncosis. Neurosci Lett 479:118-122.PubMedGoogle Scholar
  185. 185.
    Du S, A Rubin, S Klepper, et al (1999) Calcium influx and activation of calpain I mediate acute reactive gliosis in injured spinal cord. Exp Neurol 157:96-105.PubMedGoogle Scholar
  186. 186.
    Aliabadi AZ, AO Zuckermann, M Grimm (2007) Immunosuppressive therapy in older cardiac transplant patients. Drugs Aging 24:913-932.PubMedGoogle Scholar
  187. 187.
    Marks AR (1996) Cellular functions of immunophilins. Physiol Rev 76:631-649.PubMedGoogle Scholar
  188. 188.
    Aramburu J, MB Yaffe, C Lopez-Rodriguez, et al (1999) Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285:2129-2133.PubMedGoogle Scholar
  189. 189.
    Noguchi H, M Matsushita, T Okitsu, et al (2004) A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med 10:305-309.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Sanders-Brown Center on AgingUniversity of Kentucky College of MedicineLexingtonUSA

Personalised recommendations